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Abstract
Magnetic Resonance Microscopy (MRM) can provide high microstructural detail in excised human lesions. Previous MRM
images on some experimental models and a few human samples suggest the large potential of the technique. The aim of
this study was the characterization of specific morphological features of human brain tumor samples by MRM and
correlative histopathology. We performed MRM imaging and correlative histopathology in 19 meningioma and 11 glioma
human brain tumor samples obtained at surgery. To our knowledge, this is the first MRM direct structural characterization of
human brain tumor samples. MRM of brain tumor tissue provided images with 35 to 40 mm spatial resolution. The use of
MRM to study human brain tumor samples provides new microstructural information on brain tumors for better
classification and characterization. The correlation between MRM and histopathology images allowed the determination of
image parameters for critical microstructures of the tumor, like collagen patterns, necrotic foci, calcifications and/or
psammoma bodies, vascular distribution and hemorrhage among others. Therefore, MRM may help in interpreting the
Clinical Magnetic Resonance images in terms of cell biology processes and tissue patterns. Finally, and most importantly for
clinical diagnosis purposes, it provides three-dimensional information in intact samples which may help in selecting a
preferential orientation for the histopathology slicing which contains most of the informative elements of the biopsy.
Overall, the findings reported here provide a new and unique microstructural view of intact human brain tumor tissue. At
this point, our approach and results allow the identification of specific tissue types and pathological features in unprocessed
tumor samples.
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Introduction
Brain tumors affect a larger percentage of the population as
lifespan increases. In general, in western developed countries,
brain tumors represent between 1.4% and 2% of all neoplasms
[1]. Although they represent a small proportion of all cancers, they
are usually aggressive and both their mortality and their morbidity
are high [1,2]. Of all brain tumors, meningioma and glioma
together account for almost 70%. Even those considered benign
interfere with normal brain functions which are basic for normal
activity. Survival rates among patients vary considerably depend-
ing on the type and grade of the brain tumor. In most of the cases,
accurate diagnosis can significantly impact therapeutic planning
and potentially improve the clinical outcome [1,3,4]. Diagnosis
using Magnetic Resonance Imaging (MRI) is non-invasive and has
high sensitivity, but only achieves between 60 and 90% accuracy
depending on the tumor type and grade [5,6]. The current gold
standard characterization of a brain tumor is by histopathological
analysis [7]. Histopathological analysis is the standard procedure
routinely used to reveal the amount of necrosis, proliferative
regions, collagen and vascularity within the tumor area. Despite
worldwide efforts to standardize tumor evaluation criteria, the
morphological classification of some human brain tumors is
subject to interpretation. This uncertainty comes, among others,
from the intra and inter-biopsy morphological heterogeneity of
tumor tissue. In addition, the descriptive nature of morphology-
based histopathology raises some discrepancies among experts
[8,9]. In addition, potential regions of interest inside the tissue or
preferred orientation for histopathology slices are difficult to
determine before processing the sample.
High resolution MRI (resolution lower than 100 mm) is called
Magnetic Resonance Microscopy (MRM) [10,11,12]. MRM of
excised tissue provides a detailed functional and anatomical
picture of identical nature to those obtained by MRI and of higher
resolution, which may be used as a bridge between clinical MRI
and histopathology [13,14]. There are some examples of the
MRM characterization of excised tissues [15,16] suggesting the
applicability of the technique to human samples. However, up to
date only Shenkar et al have applied MRM to the study of human
excised tissue demonstrating the capabilities of MRM to detect
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tion [13]. High-field in vivo MRI may become possible in the near
future and the potential for applying this technique in the
evaluation of brain tumors would be very high. The use of MRM
to study human brain tumor tissue may provide new microstruc-
tural information on brain tumors, useful for better characteriza-
tion and better interpretation of future in vivo high field studies.
The aim of this study was the characterization by MRM of
structural and morphological features of the brain tumor, such as
calcifications, collagen patterns or presence of blood, which affect
the MR signal in the different imaging sequences. We present here
a complementary tool to the standard histopathology of tumor
biopsies that may help in selecting preferential slicing during
histology. With this purpose, we performed MRM imaging and
correlative histopathology in 30 tissue samples from brain tumor
patients. The correlation between MRM and histopathology
images allowed the determination of MRI parameters for critical
internal microstructures of the tumor.
Methods
Brain tumors samples
Brain tumor samples were obtained during surgery from
patients already diagnosed with brain tumor by conventional
MRI by the Neurosurgery Department and Anatomopathological
Department of the Hospital Clı ´nico Universitario de Valencia.
Tissue samples used in this study included 19 samples from
meningioma patients and 11 samples from glioma patients.
Patients were between 25 and 92 years old and included 16
women and 14 men. This study was conducted according to the
principles of the Declaration of Helsinki and was reviewed and
approved by the local ethics committee. Written informed consent
was obtained from all patients. All data were anonymized before
analysis. Tumors were classified according to the 2007 WHO
Histological Classification [7]. Three additional cavernoma
samples and one additional sample from control brain tissue,
obtained during the autopsy of an individual dead by no cancer
related reasons, were included in the study for comparison
purposes, for calibration of MRM sequences and for checking
consistency of our approach with respect to previous studies [13].
All samples ranged in size from 1 to 1.8 cm and were rinsed in 4%
formaldehyde for at least one month before imaging. Previous
studies show that artifacts detectable by MRI are significant only
after postmortem fixation periods longer than 5 years [17]. All our
samples were fixed for a period between 1 month and 12 months.
Before imaging a wedge was made (the reference wedge) on one
side of the samples for geometrical referencing and for geometrical
correlation between MRM images and histopathology images.
The whole protocol for sample handling and data obtaining has
been outlined in Figure 1.
Magnetic Resonance Microscopy
Just before MRM, samples were submerged in a gel matrix
(agarose 2.5%) and placed inside the imaging tube (1 cm diameter,
Cortecnet, France). Magnetic resonance images were acquired at
room temperature (25uC). High spatial resolution images were
acquired in a 14 Teslas vertical axis imager (Bruker-AVANCE 600
system, 600 MHz proton frequency, Bruker Biospin GmbH,
Rheinstetten, Germany) equipped with a 10 mm microimaging
1H coil tuned to the appropriate proton frequency. Maximal
Figure 1. Scheme showing the protocol followed in this study. Tissue samples coming from the surgery room are fixed at the
Anatomopathology Department. There, a reference cut is performed on the sample for geometrical referencing purposes. The sample is then
submerged in an agarose matrix in the MRM tube at the MR Imaging lab to minimize sample motion and magnetic susceptibility artifacts. The MRM
tube containing the sample is then introduced in the MR 14 Tesla magnet and MRM images are obtained at high resolution. Finally, the agarose
matrix is dissolved and the samples are washed with formalin and embedded in paraffin for histopathology analysis at the Anatomopathology
Department.
doi:10.1371/journal.pone.0027442.g001
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strength). Two-dimensional multi-slice spin-echo images were
acquired with different combinations of repetition time (TR) and
echo time (TE) for obtaining different image contrasts. Slice
thickness was 500 mm and the in-plane spatial resolution achieved
was up to 35 microns per pixel depending on the sequence used.
Matrix resolution was 5126512 pixels. Our standard protocol for
imaging lasted 8 hours and consisted of T1- and T2-weighted
images and proton density with the following TR/TE values: T1-
weighted image, 500 milliseconds/10 milliseconds; T2-weighted
image: 4000 milliseconds/60 milliseconds; proton density (PD)
image: 4000 milliseconds/10 milliseconds. Gradient echo images
were also acquired to obtain T2*-weighted images with TR/TE
values of 1500 milliseconds/15 milliseconds. We also acquired T2-
multiecho sequences (TR of 2000 milliseconds and variable TE
ranging from 10 to 160 milliseconds) and diffusion weighted
images (TR 1500 milliseconds, TE 15 milliseconds and b-values of
30, 49, 70, 97, 183, 298, 518, 822, 1055, 1318, 1611, 1933, 2284,
2665, 3515 and 4483 s/mm
2) both at a matrix resolution of
2566256. The measurement system allows a nearly free choice of
slice selection and orientation. We selected a slice orientation in
such a way that the reference wedge was always at the topmost
part of the slice and provided the largest slice image area.
Histopathological analysis
Once MRM images were obtained, the agarose matrix was
removed and the sample rinsed in 4% formalaldehyde. Then, the
sample was paraffin-embedded, sliced (4 microns thickness) and
examined histologically using hematoxylin and eosin (HE) dye.
Histological slicing orientation was chosen to match the MRM
images using the reference wedge and the maximal sample area
criteria.
Data analysis
R2 (which is 1/T2) and ADC maps were calculated in each
pixel of the images from the multi-echo multi-slice image sequence
and from the diffusion weighted multi-b-value image sequence,
respectively. All images were converted to DICOM standard
format and subsequently processed using MATLAB in-house
scripts. Exponential fitting was made and thus, R2 map and ADC
map were calculated for all samples in all pixels. Regions of
interest (ROIs) and subsequent analysis were selected by expert
neuropathologists based on the correlation between histological
images and MRM images (Table 1). Relative intensity was
expressed as the mean intensity in the selected ROI relative to the
mean intensity of a fixed region in the agarose matrix. R2 and
ADC values for selected ROIs are expressed as mean and standard
deviation in Table 2.
Results
MRM of brain tumor biopsies provided images with high
contrast and high geometrical resolution (35 to 40 microns).
Examples of MRM images for some brain tumors, brain lesions
and normal brain are shown in Figure 2. All MRM images
acquired and correlative histopathology are shown in the
supplementary material. The brain tumor tissue images show
good contrast with respect to the agarose matrix. Samples studied
showed heterogeneous microstructure, including blood vessels,
collagen, necrotic foci, cysts areas and calcifications. In general,
tumor samples images exhibited high structural detail. MRM
allowed, for example, the observation of peritumoral regions in
glioma (Figure 2D), the distinction between gray and white matter
in healthy brain tissue (Figure 2E), the observation of microvessels
in meningioma (Figure 2C) or the identification of caverns in
cavernomas (Figure 2A). In this sense, we obtained MRM images
for three cavernomas in order to compare our results with those
reported by Shenkar et al and therefore validate our sample
preparation protocol. Similarly to previous studies, cavernoma
MRM images exhibited a highly heterogeneous microstructure
with ‘bland’ regions which have large caverns larger than 500 um
and ‘honeycombed’ regions with smaller caverns and/or capillar-
ies [13]. These results suggest that, as expected, the agarose matrix
does not alter the sample microstructure. ADC and R2 maps
provide additional information to determine different regions in
cavernomas. The histopathology study ensures the correct
interpretation of the different MRM regions. In our study, we
used MRM for microstructural characterization of two types of
human brain tumor samples: gliomas and meningiomas. The
acquisition of different images on each sample and the comparison
with respect to histopathology (Figure 3) allowed a better
characterization of the microstructural elements present in the
samples. Table 1 shows the MRM characteristics of differential
regions within these human brain tumors.
In general, MRM images of human meningioma biopsies show
large areas of uniform signal intensity with some hypo-intense
elements spread over the entire sample (Figure 3, 4 and 5).
Meningioma tissue appears at higher intensity than the agarose
matrix in all images acquired. Due to the broad typology of
meningioma, microstructural elements observed in the different
meningioma samples are diverse. Among the different types of
meningiomas, fibroblastic and transitional meningiomas show
large areas of homogeneous signal intensity (Figures 2B and 4)
whereas microcystical and meningiothelial meningioma exhibit
some hypointense regions, which correspond to microcysts,
vessels and nodular patterns (Figures 2C and 5). Collagen
structures, which show the most extensive signal intensity
heterogeneities in MRM images of meningioma, have different
appearance in the different meningioma subtypes. The compar-
ison between MRM images and Gomori’s trichrome stains allows
the detection and correlation of collagen bands in both images.
Gomori’s trichrome stains green or blue connective tissue and
collagen. This stain allows triple staining in one step [18].
Collagen in fibroblastic and transitional meningiomas usually
appears as hypo-intense grooves in T2-weighted images and
slightly hypo-intense regions in proton density and T1-weighted
images. On the other hand, collagen in microcystical meningi-
omas appears as large slightly hypo-intense bands in T2-weighted
images. Meningiothelial meningiomas also display a variety of T2
and T2*-weighted hypo-intense microregions. Microvasculature,
Table 1. Relative MRM intensity of selected ROIs in brain
tumor tissue.
T 1 -i m a g e T 2 -i m a g e T 2 *
-image PD-image R2 map ADC
Collagen ----+ ++
Edema -- ++ ++ + ++ ++
Vasculature -- -- -- - -- +++
Calcium --- --- --- --- ++ ---
Hemorrhage + --- --- -- --- --
Necrosis -- - -- - - ++ ++
Qualitative MRM region of interest (ROI) signal intensity trend relative to
dominant tissue signal intensity for different areas as selected by expert
pathologists and defined by correlation with respect histopathology images.
doi:10.1371/journal.pone.0027442.t001
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hypo-intense in these images.
In contrast to meningioma, MRM images of human glioma
tissue show signal intensity areas of larger variability appearing in
MRM images as more heterogeneous (Figures 2, 6 and 7).
Nevertheless, all glial tumors appear with higher intensity than
agarose exhibiting some hypo-intense elements. T1 and T2-
weighted MRM images of human glial tumors show different hypo
and hyper-intense regions organized in very different patterns in
the samples studied. The combination of T1 and T2-weigthed
images together with ADC maps reveals some microstructural
elements otherwise hidden. As expected, glioblastoma multiforme,
which is a highly heterogeneous tumor, shows large areas of
necrosis and angiodysplastic microvessels. In our glioblastoma
multiforme samples we also observed, when present, tumor
infiltrative border as a slightly hypointense band in T2-weighted
images (Figure 6). Blood breakdown products appear as foci that
are highly hypo-intense in T2 and T2*-weighted images and
hyper-intense in T1-weighted images. Microvessels show hypo-
intensity in T2 and T2*-weighted images and hyper-intensity in
proton density and T1-weighted images. If present, calcium
deposits appear hypo-intense in all imaging protocols. Necrotic
foci show hypointensity in all imaging protocols, with the
exception of the ADC maps, suggesting increased water diffusion.
Interestingly, peritumoral region only exhibits differential signal
intensity in ADC images (Figure 2E) with lower water diffusion.
Many of these microstructural elements also appear in other glial
tumors. Oligodendrogliomas show large regions with homoge-
neous intensity and some smaller regions with higher concentra-
tion of hypo-intense elements. Gliosarcoma (Figure 7), which is a
less common glial tumor with very characteristic microstructural
features, shows high contrast with respect to agarose with highly
structured patterns and microelements spread all over the image.
Collagen forms large bands slightly hyperintense in T2 and T2*-
weighted images that exhibit a crossing pattern against the
surrounding hypointense dominant tissue.
We also calculated T2 relaxation times and apparent diffusion
coefficients for selected regions of interest of several brain tumor
biopsies. These values are shown in Table 2. T2 relaxation
time and apparent diffusion coefficient regional heterogeneity
allows discrimination of microstructural elements identified by
histopathology. Interestingly, some microstructural elements, such
as calcifications or collagen, exhibit different relative intensities
and T2 values in different tumor types.
Discussion
MRM studies on various samples have been carried out
previously with resolution down to several micrometers. Many of
these studies, performed on experimental models, suggest the
potential applications of MRM to the study of human brain
tumors [16,19]. To our knowledge, this is the first MRM structural
characterization of human brain tumor samples. We obtained
MRM and correlative histopathology images from nineteen
meningioma and eleven glioma human biopsies. Our protocol
enables MRM previous to histopathology of the brain tumor
sample, without altering the established clinical routine. These
results show that the spatial organization of microstructural
elements within the biopsy is preserved despite the agarose matrix
and the high magnetic field. The correlation between histopa-
thology and MRM images is critical for interpretation of results
and for the success of clinical applications of the technique. The
findings reported here provide a new and unique microstructural
view of intact human brain tumor tissue. MRM gives detailed
information about morphology, water diffusion, molecular mobil-
ity and physicochemical properties of the different elements
observed. This provides an added value, with potential diagnostic
implications, including better slice orientation selection and
therefore less sampling errors in histopathology analysis, over
conventional anatomical pathology procedures. At this point, our
approach and results allow the identification of specific tissue types
and pathological features in unprocessed tumor samples.
The MRM images of human brain tumor biopsies show high
microstructural detail. The agarose matrix provided semi-rigid
support for the sample allowing better image definition in the
sample borders. The use of an agarose matrix improves the image
quality mainly because of three reasons. First, it supports the
sample away from the bottom of the tube allowing better sample
positioning in the z-axis. Second, it minimizes the variations in
magnetic susceptibility between the sample and its surroundings.
Third, it reduces potential sample motion artifacts by the possible
gradient vibration. From a practical point of view, the agarose
Table 2. MRM parameters for different microstructural elements in brain tumor tissue.
IT1/IT1ag T2 (ms) IPD/IPDag IT2*/IT2*ag ADC (ms/s
21)
Predominant tissue (transitional meningioma) 1.7860.15 24.261.0 1.3160.11 0.8560.05 0.6960.03
Predominant tissue (meningiothelial meningioma) 1.8360.14 34.761.4 1.5260.09 1.1460.04 0.9460.12
Peritumoral region (oligodendroglioma) 1.2660.14 31.260.8 1.0760.11 0.9760.05 0.4660.04
Necrosis (glioblastoma multiforme) 1.5860.25 25.261.4 1.2760.20 1.0860.08 0.9760.08
Vasculature (meningothelial meningioma) 1.3960.06 35.862.5 1.2960.02 1.0860.05 1.2960.13
Collagen (transitional meningioma) 1.4060.06 22.661.6 1.1960.04 1.0860.01 1.5560.07
Collagen (oligodendroglioma) 1.6060.03 21.660.7 1.3560.02 1.1960.04 1.060.1
Hemorrhage (gliosarcoma) 1.6860.24 11.960.2 0.6560.09 0.1060.02 0.1660.05
Calcifications (gliosarcoma) 1.5160.20 16.960.1 0.6260.12 0.06460.002 0.2560.06
White matter (control tissue) 2.0560.14 29.061.4 1.0460.07 0.4960.05 0.1060.01
Gray matter (control tissue) 3.2760.26 27.961.4 1.8060.15 0.9760.04 0.2460.01
T2 relaxation times and ADCs of different region of interest (ROI) as selected by expert pathologists and defined by correlation with respect to histopathology images. A
T2 and apparent diffusion coefficient (ADC) value was calculated for each pixel in the selected ROI by exponential fitting of the intensity curves of the corresponding
image sequences (T2-map and ADC-map). T2 and ADC values are expressed as mean and standard deviation for all the pixels in a selected ROI.
doi:10.1371/journal.pone.0027442.t002
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(shimming) because it reduces the global magnetic susceptibility
heterogeneity of the inter-coil space. Microscopic air bubbles
trapped inside the gel matrix may generate T2* artifacts in some
images due to the abrupt difference in magnetic susceptibility
between air and agarose. However, they are usually at least 2 mm
away from the sample and do not disturb the morphological
examination of the MRM images.
Correlative MRM and histopathology allowed for quantifica-
tion of MR image intensity and microstructural properties (i.e.
ADC and T2 relaxation time) at specific region of interest defined
by a pathologist. The marking of the fixed tissue sample with a
wedge at the topmost edge allows the image registration between
MRM and histopathology slices. In the scanner, the MRM virtual
slicing geometry is selected by keeping this wedge at the top of the
slice and producing the largest tissue section area. Histopathology
slicing orientation is carefully selected to keep these very same
restraints. The resulting images allow direct comparison between
MRM and histopathology. Although in some of the individual
images only some elements were detectable based on MRM
intensities, the combination of different experiments (T1-, T2-,
T2*- weighted images, proton density images and diffusion
weighted images) provided characteristic patterns, detailed in
Table 2, that allow the identification of many elements of
pathological interest. In a few years, clinical in vivo MRI at high
fields may become possible. The correlation between MRM
patterns and histopathological features in brain tumors will
probably facilitate the interpretation of high field in vivo MRI in
patients. Our study establishes the basis of this correlation opening
new potential clinical applications of MRM. On the other hand,
the three-dimensional detection, before tissue processing, of
microstructural elements of interest in the intact biopsy offers a
unique opportunity for the pathologists to select the slicing
orientation that provides the most informative tissue sections.
The only test needed to diagnose a brain tumor is cranial MRI.
However, the gold standard for typing and grading brain tumors is
Figure 2. Magnetic Resonance Microscopy (MRM) images at 14 Tesla and 256C of different human brain excised tissue showing
different structural details in the different image sequences and brain tissues. A) Proton density spin echo image of a human cerebral
cavernous malformation (CCM) lesion biopsy showing the potential honeycomb region enclosed in a white square; B) T2-weighted spin echo image
of a human fibroblastic meningioma brain tumor; C) T2-weighted spin echo image of a human meningothelial meningioma brain tumor biopsy; D)
T2-weighted spin echo image of a human gliosarcoma brain tumor biopsy; E) ADC map of a human oligoastrocytoma showing the change in water
diffusion between the tumoral (high ADC) and peritumoral (low ADC, white arrows) regions; F) T1-weighted spin echo image of human healthy brain
showing the differences between gray (hyper-intense) and white (hypo-intense) matter.
doi:10.1371/journal.pone.0027442.g002
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according to the WHO system [1]. Accurate pathological grading
is essential because it defines treatment and prognosis. Correla-
tion between radiological and histopathological findings is of
paramount importance. Bringing together MRI and histopathol-
ogy of brain tumors may greatly benefit decision taking in brain
tumor management and may open new possibilities for accurate
in vivo tumor grading. In this work, we identified and
characterized by MRM several brain tumor microstructural
features critical for histopathology diagnosis and grading.
Presence and extension of necrotic foci, for example, are clear
markers of malignancy. In astrocytic tumors, vascular prolifera-
tion is a marker used for tumor grading. On the other hand,
vascular proliferation and necrosis are never present in low grade
astrocytoma. Tumor infiltration is also a marker of potential
relapse. In our results, the detection of differential MRM
properties in peritumoral regions correlates with lack of
infiltration in the histopathological study. In particular, non-
infiltrated peritumoral regions exhibit lower ADC values (see
Figure 2E) as the possible result of compacted extracellular space
in response to the tumor growth. Other features detected here
have also been correlated with brain tumor type or grade. Some
studies suggests that calcification in different types of brain
tumors contain different proportions of calcium, phosphorus,
magnesium, sulfur, potassium, and sodium [20]. This may
explain why the T1 and T2 intensities of calcifications vary
between samples.
The potential usefulness of the characterization of collagen
pattern and distribution for cancer diagnosis has been suggested
for many years [21]. Bolonyi studied the potential role of
differential reticulin or type III collagen distribution for patholog-
ical classification of brain tumors [22]. More recent works
reported that type IV collagen patterns in brain tumors may be
used for differential diagnosis between meningiomas and neur-
ilemmonas [23]. However, some studies suggest that silver
impregnation techniques for reticulum fibers may have low value
for determining the type III collagen molecular properties [24].
The determination of three-dimensional patterns and molecular
mobility properties of collagen fibers and bands would add some
valuable information in the interpretation of conventional collagen
stains. In glial tumors, collagen fibers are generally limited to
perivascular regions. Additionally, collagen expression and
distribution correlate to vascular patterns, cell invasion and tumor
microstructure [25,26]. On the other hand, meningiomas exhibit a
collagen arrangement that is to a great extent independent of
vessels. We also observed different collagen patterns that exhibit
minor variations in MRM signal intensity, T2 values and ADC
values, suggesting different molecular microstructure and proper-
Figure 3. Magnetic Resonance Microscopy (MRM) images at 14 Tesla and 256C of human meningioma brain tumor sample showing
the different contrasts obtained using different image sequences (A–F) and compared to correlative histopathology (G). A) T1-
weighted spin echo image; B) T2-weighted spin echo image; C) T2*-weighted gradient echo image; D) proton density weighted image; E) Apparent
Diffusion Coefficient (ADC) map calculated from multi-slice multi-b-values image sequence; F) R2 map calculated from multi-slice multiecho image
sequence; G) Hematoxylin and eosin (HE) stain at low magnification power of human meningioma brain tumor sample with two zoomed regions
showing microhemorrhages (a) and collagen pattern (b).
doi:10.1371/journal.pone.0027442.g003
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PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27442Figure 4. Magnetic Resonance Microscopy (MRM) T2-weighted image at 14 Tesla and 256C (right), correlative histopathology
hematoxylin and eosin (HE) dye (top middle and left) and correlative histopathology Gomori’s trichrome dye (bottom middle) of
human transitional meningioma tumor sample. Regions of interest containing vasculature (a) and collagen in duramadre (b) have been
highlighted and zoomed in.
doi:10.1371/journal.pone.0027442.g004
Figure 5. Magnetic Resonance Microscopy (MRM) T2-weighted image at 14 Tesla and 256C (right), correlative histopathology
hematoxylin and eosin (HE) dye (top middle and left) and correlative histopathology Gomori’s trichrome dye (bottom middle) of
human transitional meningioma tumor sample. Calcifications and psammomas bodies (a) can be seen spread all over the image as hyper
intense spots in the MRM image and dark spots in the histopathology stain.
doi:10.1371/journal.pone.0027442.g005
MRM of Human Brain Tumor Tissue
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27442Figure 6. Magnetic Resonance Microscopy (MRM) T2-weighted image at 14 Tesla and 256C (right), correlative histopathology
hematoxylin and eosin (HE) dye (top middle and left) and correlative histopathology Gomori’s trichrome dye (bottom middle) of
human glioblastoma multiforme tumor sample. Region of interest containing the tumor infiltrative border, hemorrhage and congestive
vasculature (a) and region of interest containing tumor necrotic foci (b) have been highlighted and zoomed in.
doi:10.1371/journal.pone.0027442.g006
Figure 7. Magnetic Resonance Microscopy (MRM) T2-weighted image at 14 Tesla and 256C (right), correlative histopathology
hematoxylin and eosin (HE) dye (top middle and left) and correlative histopathology Gomori’s trichrome dye (bottom middle) of
human gliosarcoma tumor sample. Regions of interest containing characteristic sarcomatous vascular and collagen pattern (a) and hemorrhage
(b) have been highlighted and zoomed in.
doi:10.1371/journal.pone.0027442.g007
MRM of Human Brain Tumor Tissue
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properties are very diverse. Molecular mobility is partially
restricted in an anisotropic manner within the fibers. For example,
an increase in the directionality of the water diffusion tensor may
result in artificially larger ADCs [27]. This may produce contrary
effects in different images. Overall, it seems that these molecular
properties detected by MRM may reflect the distinct origin of the
different collagen fibers and bands (basement membranes in
normal brain, specific vascular patterns, or epithelial linings).
However, more specific studies on this particular subject are
needed for stronger correlations between the different collagen
patterns and their MRM properties. Overall, this information on
collagen three-dimensional pattern and molecular properties
suggests an important added value for MRM in the diagnosis of
brain tumors.
T2 values and relative intensities in T1- and T2-weighted
images varied among the different structural elements in the
different tumor types. The potential explanations for this are far
from simple. Previous studies have shown that the presence or the
release to the extracellular matrix of different molecules (deox-
yhemoglobin, hemosiderin, methemoglobin, iron compounds, etc)
have strong and complex effects in tissue MRM relaxation rates
[13,28]. However, this does not preclude the association of
particular parameters to specific pathological findings. The
relaxation times and MRM relative intensities reported here
may differ to those in vivo. Physical and physiological conditions,
such as temperature, diffusion, perfusion, oxygenation, and
biomolecular structure directly affect MRM parameters [29]. In
addition, fixation causes a number of changes in the cross-linking
of proteins that affects water motility and T2 relaxation [30,31].
Therefore, the comparison between these results and in vivo
measurements require some caution. In any case, this study and
the intra-sample comparative values reported here may serve as
bases for future high field MRI studies of brain tumor tissue.
For the first time, MRM and correlative histopathology of brain
tumor biopsies yield high detail structural information. MRM
provides detailed information about physicochemical properties of
the different tissues analyzed, which constitutes an added value
over conventional histopathology observations. The use of MRM
to study human brain tumor samples may have a three-fold benefit
with potential diagnostic implications. First, it may provide new
microstructural information on brain tumors for better classifica-
tion and characterization. Second, it may help in the interpreta-
tion of MRI clinical images in terms of cell biology processes and
tissue patterns. And third, and most importantly for clinical
diagnosis purposes, as it provides 3D information in intact
samples, it may help in selecting a preferential orientation for
the histopathology slicing which contains most of the informative
elements of the biopsy.
Brain tumor MRM images show high heterogeneity both inter
and intra-sample. The combination of different MRM images and
R2 and ADC maps provides unique patterns for the identification
of specific microstructural elements. We report MRM parameters
for different pathological features representative of brain tumor
type and grade, like necrotic foci, hemorrhage, vascular pattern,
collagen bands and calcifications, among others. The techniques
and analysis presented here provide the basis for standardized
MRM examinations of brain tumor samples.
The MRM analysis of meningioma and glioma samples
revealed microstructural details of these tumors, which added
some structural information for clinical MRI images interpreta-
tion. We believe that our results have also potential pathobiolo-
gical significance as MRM is capable of exploring the tissue
sample before processing.
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